Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin effects on gut microbiota in healthy men
NCT02546050Phase 1Completed
- Start
- Jun 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of metformin in type 2 diabetes mellitus (T2DM). Primary endpoint: Structural changes in the human gut microbiota at 18 weeks. Started Jun 2015; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02546050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02546050.